Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review

Abstract

BackgroundGlioma patients suffer from a wide range of symptoms which influence quality of life negatively. The aim of this review is to give an overview of symptoms most prevalent in glioma patients throughout the total disease trajectory, to be used as a basis for the development of a specific glioma Patient Reported Outcome Measure (PROM) for early assessment and monitoring of symptoms in glioma patients.MethodsA systematic review focused on symptom prevalence in glioma patients in different phases of disease and treatment was performed in MEDLINE, CINAHL and EMBASE according to PRISMA recommendations. We calculated weighted means for prevalence rates per symptom.ResultsThe search identified 2.074 unique papers, of which 32 were included in this review. In total 25 symptoms were identified. The ten most prevalent symptoms were: seizures (37%), cognitive deficits (36%), drowsiness (35%), dysphagia (30%), headache (27%), confusion (27%), aphasia (24%), motor deficits (21%), fatigue (20%) and dyspnea (20%).ConclusionsEight out of ten of the most prevalent symptoms in glioma patients are related to the central nervous system and therefore specific for glioma. Our findings emphasize the importance of tailored symptom care for glioma patients and may aid in the development of specific PROMs for glioma patients in different phases of the disease.Electronic supplementary materialThe online version of this article (10.1007/s11060-018-03015-9) contains supplementary material, which is available to authorized users.

Pathogenesis of peritumoral hyperexcitability in an immunocompetent CRISPR-based glioblastoma model

“…These pathological waves involve massive intracellular calcium influx mediated in part by NMDA receptor activation that transiently silences neuronal activity and briefly impairs the precise coding of high-frequency synaptic inputs in recovering neurons (55). SD appearance in brain tumors is of clinical relevance and may contribute to common transient neurological symptoms including confusional spells, motor deficits, and headache in glioma patients (56).…”

Palliative Care in High-Grade Glioma: A Review

“…In a review of 32 studies, 25 common symptoms were identified in glioblastoma patients, with the following being most prevalent: seizures (37%), cognitive deficits (36%), drowsiness (35%), dysphagia (30%), headache (27%), confusion (27%), aphasia (24%), motor deficits (21%), fatigue (20%) and dyspnea (20%). [ 15 ] There is variability within the disease trajectory, with more headache and dizziness at the time of diagnosis, higher rates of treatment side effects during the follow-up phase, and more drowsiness, fatigue, and neurologic deficits in the end-of-life phase. Symptom burden increases during active HGG treatment and hospitalizations, and there is a phase of significant and progressive worsening at the end of life.…”

CapsNet topology to classify tumours from brain images and comparative evaluation

“…The term glioma is a general name of different types of gliomas, such as glioblastoma (high‐grade tumour), oligodendroglioma or astrocytoma. According to a recent review study, there are 25 symptoms (such as anorexia, cognitive deficits, alopecia and anxiety/depression) in glioma patients in different phases [3]. The five most common symptoms are headache (27%), dysphagia (30%), drowsiness (35%), cognitive deficits (36%) and seizures (37%) [3].…”

“…According to a recent review study, there are 25 symptoms (such as anorexia, cognitive deficits, alopecia and anxiety/depression) in glioma patients in different phases [3]. The five most common symptoms are headache (27%), dysphagia (30%), drowsiness (35%), cognitive deficits (36%) and seizures (37%) [3]. The most prevalent type of glioma is glioblastoma that can evolve rapidly over several weeks.…”